Yoshikawa, Takaki
Sano, Takeshi
Terashima, Masanori
Yamaguchi, Kensei
Bando, Etsuro
Kawabata, Ryohei
Yabusaki, Hiroshi
Shinohara, Hisashi
Oba, Mari S.
Kimura, Tetsuya
Takita, Atsushi
Sasako, Mitsuru
Clinical trials referenced in this document:
Documents that mention this clinical trial
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
https://doi.org/10.1007/s10120-023-01378-1
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
https://doi.org/10.1007/s00535-023-02033-3
Funding for this research was provided by:
Daiichi Sankyo Co., Ltd.
Article History
Received: 30 August 2022
Accepted: 26 February 2023
First Online: 1 April 2023
Declarations
:
: Takaki Yoshikawa received consultant fees from Daiichi Sankyo Co., Ltd. related to the submitted work, and received lecture fees from Covidien Japan, Inc., Otsuka Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., MSD K.K., Terumo Corp., EA pharma Co., Ltd., and Eli Lilly Japan K.K. outside the submitted work. Takeshi Sano received lecture fees from Taiho Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., and Ono Pharmaceutical Co., Ltd., outside the submitted work. Masanori Terashima received consultant fees from Daiichi Sankyo Co., Ltd. related to the submitted work, and received lecture fees from Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Bristol-Myers Squibb K.K., Yakult Honsha Co., Ltd., Takeda Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Pfizer Japan Inc., Daiichi Sankyo Co., Ltd., Johnson & Johnson K.K., Medtronic Japan Co., Ltd., Intuitive Surgical Japan Inc., and Olympus Corp, outside the submitted work. Kensei Yamaguchi received consulting fees from Daiichi Sankyo Co., Ltd. related to the submitted work, and received lecture fees from Daiichi Sankyo Co., Ltd., Chugai Pharmaceutical Co., Ltd., Bristol-Myers Squibb K.K., Eli Lilly Japan K.K., Taiho Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Merck Biopharm Co., Ltd., outside the submitted work. Etsuro Bando received lecture fees from Johnson & Johnson K.K., Covidien Japan Inc., Intuitive Surgical Inc., and Kaken Pharmaceutical Co., Ltd., outside the submitted work. Hisashi Shinohara received lecture fees from Johnson & Johnson K.K., Medtronic Japan Co., Ltd., Olympus Corp., Taiho Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Bristol-Myers Squibb K.K., MSD K.K., Terumo Corp., and Eli Lilly Japan K.K outside the submitted work. Mari S Oba received lecture fees from SAS Institute Inc., EP SOGO Co., Ltd., Pfizer Japan Inc., and AstraZeneca K.K. related to the submitted work. Tetsuya Kimura and Atsushi Takita are employees of Daiichi Sankyo Co., Ltd. Mitsuru Sasako received lecture and consulting fees from Daiichi Sankyo Co., Ltd. related to the submitted work, and received lecture and consulting fees from Ono Pharmaceutical Co., Ltd., and lecture fees from Ono Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Nippon Kayaku Co., Ltd., Taiho Pharmaceutical Co., Ltd., and Chugai Pharmaceutical Co., Ltd. outside the submitted work. Ryohei Kawabata and Hiroshi Yabusaki have no conflicts of interest to declare.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent to be included in the study was obtained from all patients.